SOST Is a Ligand for LRP5/LRP6 and a Wnt Signaling Inhibitor
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Sclerosteosis is an autosomal recessive disease that is characterized by overgrowth of bone tissue and is linked to mutations in the gene encoding the secreted protein SOST. Sclerosteosis shares remarkable similarities with "high bone mass" diseases caused by "gain-of-function" mutations in the LRP5 gene, which encodes a coreceptor for Wnt signaling proteins. We show here that SOST antagonizes Wnt signaling in Xenopus embryos and mammalian cells by binding to the extracellular domain of the Wnt coreceptors LRP5 and LRP6 and disrupting Wnt-induced Frizzled-LRP complex formation. Our findings suggest that SOST is an antagonist for Wnt signaling and that the loss of SOST function likely leads to the hyperactivation of Wnt signaling that underlies bone overgrowth seen in sclerosteosis patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The SOST protein can also bind to LRP5/6 where it can antagonize Wnt signaling.25”
From Wnt signal transduction pathways (2008) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon Carcinoma
Korinek, V., Barker, N., Morin, P. J., van Wichen, D., de Weger, R., Kinzler, K. W., Vogelstein, B., & Clevers, H. (1997) · Science · doi:10.1126/science.275.5307.1784 · Cited by 2,905
LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development
Gong, Y., Slee, R. B., Fukai, N., Rawadi, G., Roman-Roman, S., Reginato, A. M., Wang, H., Cundy, T., Glorieux, F. H., Lev, D., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00571-2 · Cited by 2,235
Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction
Glinka, A., Wu, W., Delius, H., Monaghan, A. P., Blumenstock, C., & Niehrs, C. (1998) · Nature · doi:10.1038/34848 · Cited by 1,608
High Bone Density Due to a Mutation in LDL-Receptor–Related Protein 5
Boyden, L. M., Mao, J., Belsky, J., Mitzner, L., Farhi, A., Mitnick, M. A., Wu, D., Insogna, K., & Lifton, R. P. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013444 · Cited by 1,591
Sclerostin Binds to LRP5/6 and Antagonizes Canonical Wnt Signaling
Li, X., Zhang, Y., Kang, H., Liu, W., Liu, P., Zhang, J., Harris, S. E., & Wu, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413274200 · Cited by 1,366
Little, R. D., Folz, C., Manning, S. P., Swain, P. M., Zhao, S.-C., Eustace, B., Lappe, M. M., Spitzer, L., Zweier, S., Braunschweiger, K., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/338450 · Cited by 1,282
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
Balemans, W. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.5.537 · Cited by 1,147
LDL-receptor-related proteins in Wnt signal transduction
Tamai, K., Semenov, M., Kato, Y., Spokony, R., Liu, C., Katsuyama, Y., Hess, F., Saint-Jeannet, J.-P., & He, X. (2000) · Nature · doi:10.1038/35035117 · Cited by 1,128
Self-citationOsteocyte control of bone formation via sclerostin, a novel BMP antagonist
Winkler, D. G. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg599 · Cited by 1,112
An LDL-receptor-related protein mediates Wnt signalling in mice
Pinson, K. I., Brennan, J., Monkley, S., Avery, B. J., & Skarnes, W. C. (2000) · Nature · doi:10.1038/35035124 · Cited by 1,086
Cited by
Items 101–200 of 859
Gaudio, A., Privitera, F., Battaglia, K., Torrisi, V., Sidoti, M. H., Pulvirenti, I., Canzonieri, E., Tringali, G., & Fiore, C. E. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1901 · Cited by 183
Lenk, G. M., Tromp, G., Weinsheimer, S., Gatalica, Z., Berguer, R., & Kuivaniemi, H. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-237 · Cited by 183
Wei, Q., Yokota, C., Semenov, M. V., Doble, B., Woodgett, J., & He, X. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701927200 · Cited by 182
Self-citationWnt signaling in bone metabolism
Kubota, T., Michigami, T., & Ozono, K. (2009) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-009-0064-8 · Cited by 180
Osteocyte-specific WNT1 regulates osteoblast function during bone homeostasis
Joeng, K. S., Lee, Y.-C., Lim, J., Chen, Y., Jiang, M.-M., Munivez, E., Ambrose, C., & Lee, B. H. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92617 · Cited by 180
Cohen-Kfir, E., Artsi, H., Levin, A., Abramowitz, E., Bajayo, A., Gurt, I., Zhong, L., D'Urso, A., Toiber, D., Mostoslavsky, R., et al. (2011) · Endocrinology · doi:10.1210/en.2011-1128 · Cited by 179
Distinct Modes of Inhibition by Sclerostin on Bone Morphogenetic Protein and Wnt Signaling Pathways
Krause, C., Korchynskyi, O., de Rooij, K., Weidauer, S. E., de Gorter, D. J. J., van Bezooijen, R. L., Hatsell, S., Economides, A. N., Mueller, T. D., Löwik, C. W. G. M., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.153890 · Cited by 178
Bone Mineral Density in Sclerosteosis; Affected Individuals and Gene Carriers
Gardner, J. C., van Bezooijen, R. L., Mervis, B., Hamdy, N. A. T., Löwik, C. W. G. M., Hamersma, H., Beighton, P., & Papapoulos, S. E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1235 · Cited by 178
Sapir-Koren, R., & Livshits, G. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2808-0 · Cited by 176
Signaling in Cell Differentiation and Morphogenesis
Basson, M. A. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008151 · Cited by 176
Sclerostin influences body composition by regulating catabolic and anabolic metabolism in adipocytes
Kim, S. P., Frey, J. L., Li, Z., Kushwaha, P., Zoch, M. L., Tomlinson, R. E., Da, H., Aja, S., Noh, H. L., Kim, J. K., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707876115 · Cited by 176
Regulation of Wnt/β-catenin signaling within and from osteocytes
Burgers, T. A., & Williams, B. O. (2013) · Bone · doi:10.1016/j.bone.2013.02.022 · Cited by 144
Wnt signaling and skeletal development
Liu, F., Kohlmeier, S. E., & Wang, C.-Y. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.11.011 · Cited by 176
Baarsma, H. A., Königshoff, M., & Gosens, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.002 · Cited by 175
Role of Wnt Signaling in Adult Hippocampal Neurogenesis in Health and Disease
Arredondo, S. B., Valenzuela-Bezanilla, D., Mardones, M. D., & Varela‐Nallar, L. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00860 · Cited by 174
Wnt/β-catenin signaling in adult mammalian epithelial stem cells
Kretzschmar, K., & Clevers, H. C. (2017) · Developmental Biology · doi:10.1016/j.ydbio.2017.05.015 · Cited by 170
Bone mass is inversely proportional to Dkk1 levels in mice
MacDonald, B. T., Joiner, D. M., Oyserman, S. M., Sharma, P., Goldstein, S. A., He, X., & Hauschka, P. V. (2007) · Bone · doi:10.1016/j.bone.2007.05.009 · Cited by 169
Self-citationWnt/β-catenin Signaling in Normal and Cancer Stem Cells
Valkenburg, K. C., Graveel, C. R., Zylstra-Diegel, C. R., Zhong, Z., & Williams, B. O. (2011) · Cancers · doi:10.3390/cancers3022050 · Cited by 140
LRP5 and LRP6 in Wnt Signaling: Similarity and Divergence
Ren, Q., Chen, J., & Liu, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.670960 · Cited by 168
Wnt Antagonists Bind through a Short Peptide to the First β-Propeller Domain of LRP5/6
Bourhis, E., Wang, W., Tam, C., Hwang, J., Zhang, Y., Spittler, D., Huang, O. W., Gong, Y., Estevez, A., Zilberleyb, I., et al. (2011) · Structure · doi:10.1016/j.str.2011.07.005 · Cited by 168
Haÿ, E., Laplantine, E., Geoffroy, V., Frain, M., Kohler, T., Müller, R., & Marie, P. J. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00349-08 · Cited by 146
Saini, V., Marengi, D. A., Barry, K. J., Fulzele, K. S., Heiden, E., Liu, X., Dedic, C., Maeda, A., Lotinun, S., Baron, R., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.441360 · Cited by 167
Sclerostin Regulates Release of Bone Mineral by Osteocytes by Induction of Carbonic Anhydrase 2
Kogawa, M., Wijenayaka, A. R., Ormsby, R. T., Thomas, G. P., Anderson, P. H., Bonewald, L. F., Findlay, D. M., & Atkins, G. J. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2003 · Cited by 153
Vlashi, R., Zhang, X., Wu, M., & Chen, G. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2022.07.011 · Cited by 165
“SOST is a glycoprotein rich in cysteine that acts as an inhibitor of the Wnt pathway, by blocking LRP5/6 co-receptors’ activity.(170,171) SOST transcripts are found in high levels in osteocytes as well as in bone marrow and cartilage.”
BackgroundEttenberg, S. A., Charlat, O., Daley, M. P., Liu, S., Vincent, K. J., Stuart, D. D., Schuller, A. G., Yuan, J., Ospina, B., Green, J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007428107 · Cited by 150
Yu, B., Zhao, X., Yang, C., Crane, J., Xian, L., Lu, W., Wan, M., & Cao, X. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1663 · Cited by 147
Wnt-Lrp5 Signaling Regulates Fatty Acid Metabolism in the Osteoblast
Frey, J. L., Li, Z., Ellis, J. M., Zhang, Q., Farber, C. R., Aja, S., Wolfgang, M. J., Clemens, T. L., & Riddle, R. C. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.01343-14 · Cited by 162
Current advances in regulation of bone homeostasis
Al‐Bari, M. A. A., & Mamun, A. A. (2020) · FASEB BioAdvances · doi:10.1096/fba.2020-00058 · Cited by 162
Crosstalk between Wnt and bone morphogenic protein signaling: A turbulent relationship
Itasaki, N., & Hoppler, S. (2010) · Developmental Dynamics · doi:10.1002/dvdy.22009 · Cited by 161
McCubrey, J. A., Rakus, D., Gizak, A., Steelman, L. S., Abrams, S. L., Lertpiriyapong, K., Fitzgerald, T. L., Yang, L. V., Montalto, G., Cervello, M., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.09.004 · Cited by 161
Wnt–β-catenin signaling in the pathogenesis of osteoarthritis
Corr, M. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0904 · Cited by 160
The Binding Between Sclerostin and LRP5 is Altered by DKK1 and by High-Bone Mass LRP5 Mutations
Balemans, W., Piters, E., Cleiren, E., Ai, M., Wesenbeeck, L. V., Warman, M. L., & Hul, W. V. (2008) · Calcified Tissue International · doi:10.1007/s00223-008-9130-9 · Cited by 160
New developments in biological markers of bone metabolism in osteoporosis
Garnero, P. (2014) · Bone · doi:10.1016/j.bone.2014.05.016 · Cited by 160
Emerging therapeutic opportunities for skeletal restoration
Kawai, M., Mödder, U. I., Khosla, S., & Rosen, C. J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3299 · Cited by 159
Armamento-Villareal, R., Sadler, C., Napoli, N., Shah, K., Chode, S., Sinacore, D. R., Qualls, C., & Villareal, D. T. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1560 · Cited by 158
“Sclerostin is a secreted Wnt antagonist that regulates bone mass by binding to LRP5/6 and inhibiting the canonical Wnt/ b-catenin signaling, resulting in inhibition of osteoblastic proliferation and differentiation, thus reduced bone formation.((7,8)) Animal studies indicate an increase in sclerostin levels in experim…”
BackgroundWNT secretion and signalling in human disease
Herr, P., Hausmann, G., & Basler, K. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.06.008 · Cited by 158
Lrp5 and Lrp6 redundantly control skeletal development in the mouse embryo
Joeng, K. S., Schumacher, C. A., Zylstra-Diegel, C. R., Long, F., & Williams, B. O. (2011) · Developmental Biology · doi:10.1016/j.ydbio.2011.08.020 · Cited by 148
Gli1+ Periodontium Stem Cells Are Regulated by Osteocytes and Occlusal Force
Men, Y., Wang, Y., Yi, Y., Jing, D., Luo, W., Shen, B., Stenberg, W. V., Chai, Y., Ge, W., Feng, J. Q., et al. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.06.006 · Cited by 156
The Wnt signaling pathway and bone metabolism
Johnson, M. L., & Kamel, M. A. (2007) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32816e06f9 · Cited by 151
Molecular Bases of the Regulation of Bone Remodeling by the Canonical Wnt Signaling Pathway
Glass, D. A., & Karsenty, G. (2006) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(05)73002-7 · Cited by 150
Piters, E., Boudin, E., & Hul, W. V. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.03.006 · Cited by 149
Sclerostin in Mineralized Matrices and van Buchem Disease
van Bezooijen, R. L., Bronckers, A. L., Gortzak, R. A., Hogendoorn, P. C. W., van der Wee-Pals, L., Balemans, W., Oostenbroek, H. J., Van Hul, W., Hamersma, H., Dikkers, F. G., et al. (2009) · Journal of Dental Research · doi:10.1177/0022034509338340 · Cited by 138
Structural and Functional Studies of LRP6 Ectodomain Reveal a Platform for Wnt Signaling
Chen, S., Bubeck, D., MacDonald, B. T., Liang, W.-X., Mao, J.-H., Malinauskas, T., Llorca, O., Aricescu, A. R., Siebold, C., He, X., et al. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.09.007 · Cited by 136
Self-citationWnt/β-catenin signaling in heart regeneration
Ozhan, G., & Weidinger, G. (2015) · Cell Regeneration · doi:10.1186/s13619-015-0017-8 · Cited by 119
microRNA regulation of Wnt signaling pathways in development and disease
Song, J. L., Nigam, P., Tektas, S. S., & Selva, E. M. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.03.018 · Cited by 145
WNT signaling in bone development and homeostasis
Zhong, Z., Ethen, N. J., & Williams, B. O. (2014) · WIREs Developmental Biology · doi:10.1002/wdev.159 · Cited by 125
Adverse effects of hyperlipidemia on bone regeneration and strength
Pirih, F. Q. M., Lu, J., Ye, F., Bezouglaia, O., Atti, E., Ascenzi, M., Tetradis, S., Demer, L. L., Aghaloo, T. L., & Tintut, Y. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.541 · Cited by 143
Maupin, K. A., Droscha, C. J., & Williams, B. O. (2013) · Bone Research · doi:10.4248/br201301004 · Cited by 142
WNT Signaling and Bone: Lessons From Skeletal Dysplasias and Disorders
Huybrechts, Y., Mortier, G. R., Boudin, E., & Hul, W. V. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00165 · Cited by 140
Serum Sclerostin Increases in Healthy Adult Men during Bed Rest
Spatz, J. M., Fields, E. E., Yu, E. W., Pajevic, P. D., Bouxsein, M. L., Sibonga, J. D., Zwart, S. R., & Smith, S. M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1579 · Cited by 133
Lintern, K. B., Guidato, S., Rowe, A., Saldanha, J. W., & Itasaki, N. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.025478 · Cited by 121
Identification of a Novel Inhibitor of the Canonical Wnt Pathway
Park, K., Lee, K., Zhang, B., Zhou, T., He, X., Gao, G., Murray, A. R., & Ma, J.-X. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01211-10 · Cited by 128
Self-citationWnt signaling and the regulation of bone mass
Baron, R., & Rawadi, G. (2007) · Current Osteoporosis Reports · doi:10.1007/s11914-007-0006-0 · Cited by 137
Ohkawara, B., Cabrera‐Serrano, M., Nakata, T., Milone, M., Asai, N., Ito, K., Ito, M., Masuda, A., Ito, Y., Engel, A. G., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt578 · Cited by 137
Yamamoto, M., Yamauchi, M., & Sugimoto, T. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2143 · Cited by 127
Arenas, E. (2014) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mju001 · Cited by 120
Rybchyn, M. S., Slater, M., Conigrave, A. D., & Mason, R. S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.251116 · Cited by 134
DKK1 Antagonizes Wnt Signaling without Promotion of LRP6 Internalization and Degradation
Semënov, M. V., Zhang, X., & He, X. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800014200 · Cited by 133
Self-citationChang, M.-K., Kramer, I., Huber, T., Kinzel, B., Guth-Gundel, S., Leupin, O., & Kneissel, M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1413828111 · Cited by 120
Signaling pathways governing osteoblast proliferation, differentiation and function.
Chau, J. F. L., Leong, W. F., & Li, B. (2009) · PubMed · doi:10.14670/hh-24.1593 · Cited by 132
Is Wnt signalling the final common pathway leading to bone formation?
Milat, F., & Ng, K. W. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.06.002 · Cited by 131
Sclerostin and Osteocalcin: Candidate Bone-Produced Hormones
Wang, J. S., Mazur, C. M., & Wein, M. N. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.584147 · Cited by 130
Serum Sclerostin and Risk of Hip Fracture in Older Caucasian Women
Arasu, A., Cawthon, P. M., Lui, L.-Y., Do, T. P., Arora, P. S., Cauley, J. A., Ensrud, K. E., Cummings, S. R., & The Study of Osteoporotic Fractures Research Group (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3419 · Cited by 119
Does osteocytic SOST suppression mediate PTH bone anabolism?
Krämer, I., Keller, H., Leupin, O., & Kneissel, M. (2010) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2009.12.002 · Cited by 128
Sclerostin antibody stimulates bone regeneration after experimental periodontitis
Taut, A. D., Jin, Q., Chung, J., Galindo‐Moreno, P., Yi, E., Sugai, J. V., Ke, H. Z., Liu, M., & Giannobile, W. V. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1984 · Cited by 127
Sclerostin: A gem from the genome leads to bone-building antibodies
Pászty, C., Turner, C. H., & Robinson, M. K. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.161 · Cited by 127
Functions of the osteocyte network in the regulation of bone mass
Komori, T. (2013) · Cell and Tissue Research · doi:10.1007/s00441-012-1546-x · Cited by 111
Eight genes are highly associated with BMD variation in postmenopausal Caucasian women
Reppe, S., Refvem, H., Gautvik, V. T., Olstad, O. K., Høvring, P. I., Reinholt, F. P., Holden, M., Frigessi, A., Jemtland, R., & Gautvik, K. M. (2009) · Bone · doi:10.1016/j.bone.2009.11.007 · Cited by 125
Molecular mechanisms of inflammatory bone damage: emerging targets for therapy
Herman, S., Krönke, G., & Schett, G. A. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.04.001 · Cited by 122
Su, J.-L., Chiou, J., Tang, C.-H., Zhao, M., Tsai, C.-H., Chen, P.-S., Chang, Y.-W., Chien, M.-H., Peng, C.-Y., Hsiao, M., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.087122 · Cited by 121
Mechanical Load Increases in Bone Formation via a Sclerostin-Independent Pathway
Morse, A., McDonald, M. M., Kelly, N. H., Melville, K. M., Schindeler, A., Krämer, I., Kneissel, M., van der Meulen, M. C. H., & Little, D. G. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2278 · Cited by 120
Chandra, A., Lin, T., Young, T., Tong, W., Ma, X., Tseng, W.-J., Kramer, I., Kneissel, M., Levine, M. A., Zhang, Y., et al. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2996 · Cited by 115
The role of miR‐29 family in disease
Horita, M., Farquharson, C., & Stephen, L. A. (2021) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29896 · Cited by 119
Genetics of osteoporosis: accelerating pace in gene identification and validation
Li, W., Hou, S.-X., Yu, B., Li, M., Férec, C., & Chen, J. (2009) · Human Genetics · doi:10.1007/s00439-009-0773-z · Cited by 118
Korvala, J., Jüppner, H., Mäkitie, O., Sochett, E., Schnabel, D., Mora, S., Bartels, C. F., Warman, M. L., Deraska, D., Cole, W. G., et al. (2012) · BMC Medical Genetics · doi:10.1186/1471-2350-13-26 · Cited by 110
Crosstalk Between MLO‐Y4 Osteocytes and C2C12 Muscle Cells Is Mediated by the Wnt/β‐Catenin Pathway
Huang, J., Romero‐Suarez, S., Lara, N., Mo, C., Kaja, S., Brotto, L., Dallas, S. L., Johnson, M. L., Jähn, K., Bonewald, L. F., et al. (2017) · JBMR Plus · doi:10.1002/jbm4.10015 · Cited by 107
Novel actions of sclerostin on bone
Holdsworth, G., Roberts, S. J., & Ke, H. Z. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0176 · Cited by 118
Targeting Wnt Pathways in Disease
Zimmerman, Z. F., Moon, R. T., & Chien, A. J. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008086 · Cited by 116
Lrp4 in osteoblasts suppresses bone formation and promotes osteoclastogenesis and bone resorption
Xiong, L., Jung, J.-U., Wu, H., Xia, W.-F., Pan, J.-X., Shen, C., Mei, L., & Xiong, W.-C. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1419714112 · Cited by 103
Mechanisms of Wnt signaling and control
Grainger, S. J., & Willert, K. (2018) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1422 · Cited by 108
Schwaninger, R., Rentsch, C. A., Wetterwald, A., van der Horst, G., van Bezooijen, R. L., van der Pluijm, G., Löwik, C. W. G. M., Ackermann, K., Pyerin, W. G., Hamdy, F. C., et al. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.051276 · Cited by 107
Sclerostin and DKK1 in postmenopausal osteoporosis treated with denosumab
Gatti, D., Viapiana, O., Fracassi, E., Idolazzi, L., Dartizio, C., Povino, M. R., Adami, S., & Rossini, M. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1681 · Cited by 102
Holdsworth, G., Slocombe, P., Doyle, C., Sweeney, B., Veverka, V., Le Riche, K., Franklin, R. J., Compson, J., Brookings, D., Turner, J., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.350108 · Cited by 97
A complex interaction between Wnt signaling and TNF-α in nucleus pulposus cells
Hiyama, A., Yokoyama, K., Nukaga, T., Sakai, D., & Mochida, J. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4379 · Cited by 106
Moriishi, T., Fukuyama, R., Ito, M., Miyazaki, T., Maeno, T., Kawai, Y., Komori, H., & Komori, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040143 · Cited by 105
Muñoz-Castañeda, J. R., Rodelo‐Haad, C., de Mier, M. V. P.-R., Martín‐Malo, A., Santamaría, R., & Rodríguez, M. (2020) · Toxins · doi:10.3390/toxins12030185 · Cited by 105
PTH Stimulates Bone Formation in Mice Deficient in Lrp5
Iwaniec, U. T., Wronski, T. J., Liu, J., Rivera, M. F., Arzaga, R. R., Hansen, G., & Brommage, R. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.061118 · Cited by 101
Agonists and Antagonists of TGF-β Family Ligands
Chang, C. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021923 · Cited by 94
Sclerostin: from bench to bedside
Tanaka, S., & Matsumoto, T. (2020) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-020-01176-0 · Cited by 103
Etiology and Pathogenesis of Psoriatic Arthritis
Barnas, J. L., & Ritchlin, C. T. (2015) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2015.07.006 · Cited by 103
Manna, F. L., Karkampouna, S., Zoni, E., Menna, M. D., Hensel, J., Thalmann, G. N., & Julio, M. K. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a033688 · Cited by 101
Balemans, W., Devogelaer, J., Cleiren, E., Piters, E., Caussin, E., & Hul, W. V. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070211 · Cited by 101
Wnt signalling pathway: a new target for the treatment of osteoporosis
Rawadi, G., & Roman-Roman, S. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.5.1063 · Cited by 93
Editorial: Sclerostin and Wnt Signaling—The Pathway to Bone Strength
Ott, S. M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2370 · Cited by 99
Absence of sclerostin adversely affects B-cell survival
Cain, C. J., Rueda, R., McLelland, B., Collette, N. M., Loots, G. G., & Manilay, J. O. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1608 · Cited by 87
Roles of Non-Canonical Wnt Signalling Pathways in Bone Biology
Lojk, J., & Marc, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910840 · Cited by 97
Can we stop progression of ankylosing spondylitis?
Schett, G. A., & Rudwaleit, M. (2010) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2010.01.005 · Cited by 97
Robling, A. G., Kedlaya, R., Ellis, S. N., Childress, P., Bidwell, J. P., Bellido, T., & Turner, C. H. (2011) · Endocrinology · doi:10.1210/en.2011-0049 · Cited by 95
An Eye on the Wnt Inhibitory Factor Wif1
Poggi, L., Casarosa, S., & Carl, M. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00167 · Cited by 95
Romosozumab in osteoporosis: yesterday, today and tomorrow
Wu, D., Li, L., Wen, Z., & Wang, G. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04563-z · Cited by 95
Metadata
- Authors
- Semënov, M., Tamai, K., & He, X.
- Affiliations
- Boston Children's Hospital (US)
- Corresponding author
- He, Xi
- ORCID
- He, Xi
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-07
- Volume
- 280
- Issue
- 29
- Pages
- 26770-26775
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2002725330
- Cited by
- 771
- References
- 42
- Citations by year
- 2026: 20 · 2025: 9 · 2024: 22 · 2023: 32 · 2022: 32 · 2021: 36 · 2020: 42 · 2019: 29 · 2018: 34 · 2017: 44 · 2016: 50 · 2015: 53 · 2014: 51 · 2013: 51 · 2012: 50
- FWCI
- 10.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5555 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- W. M. Keck Foundation
- Uehara Memorial Foundation
- National Institutes of Health
- National Institute of General Medical Sciences (GM057603)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Keywords
- sclerostin, sclerosteosis, LRP5, LRP6, Wnt signaling, ligand binding, bone overgrowth, high bone mass, gain-of-function mutations, Xenopus embryo
- MeSH terms
- Animals, Bone Diseases, Developmental, Cell Line, Embryo, Mammalian, Embryo, Nonmammalian, Genetic Markers, Humans, Ligands, Protein Binding, Proteins, Receptors, LDL, Transfection, Xenopus, Signal Transduction, Bone Morphogenetic Proteins, Body Patterning, LDL-Receptor Related Proteins, Intercellular Signaling Peptides and Proteins, Adaptor Proteins, Signal Transducing, Wnt Proteins, Frizzled Receptors, Low Density Lipoprotein Receptor-Related Protein-6, Low Density Lipoprotein Receptor-Related Protein-5
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.